Harnessing placental cells to treat disease
Celularity develops placental-derived therapies for oncology and immunomodulation, with GMP-certified production and Phase II/III trials.
Celularity develops placental-derived therapies for oncology and immunomodulation, with GMP-certified production and Phase II/III trials.